In another study, Lampe employed nanodelivery technology to administer the drug cabazitaxel, resulting in increased expression of phosphorylated cofilin at Ser3, impacting cancer cell migration and invasion pathways (Lampe et al., 2023). The gene discussed is CFL1; the disease is cancer.